Source tracing of chromium-, manganese-, nickel- and zinc-containing particles (PM<Subscript>10</Subscript>) by micro-PIXE spectrum

Due to the interesting anti-proliferative properties of gallium-thiosemicarbazone complexes, the production of [⁶⁷Ga]labeled 2-acetylpyridine 4,4-dimethyl thiosemicarbazone (APTSM₂) was investigated. The freshly prepared [⁶⁷Ga]GaCl₃ was mixed with 2-acetylpyridine 4,4-dimethyl thiosemicarbazone for 60 minutes at 90 °C to yield [⁶⁷Ga]APTSM₂ with a radiochemical yield of more than 98%. Radio-thin-layer-chromatography (RTLC) showed a radiochemical purity of more than 99%. A specific activity of about 370–740 MBq/mmol (10–20 Ci/mmol) was obtained. The stability of the final product was checked in the absence and presence of human serum at 37 °C. The partition coefficient of the final complex was also determined. The biodistribution of the labeled compound in normal rats was compared with that of free Ga³⁺ cation up to 22 hours.     

Preparation and evaluation of [<Superscript>201</Superscript>Tl](III)-DTPA complex for cell labeling

Due to interesting physical properties and wide availability of ²⁰¹Tl as a SPECT radionuclide, the incorporation of this nuclide into DTPA for cell labeling was targeted. Thallium-201 (T _1/2 = 3.04 d) in Tl⁺ form was converted to Tl³⁺ cation in the presence of O₃/6M HCl and di-isopropyl ether, controlled by RTLC/gel electrophoresis methods. The final evaporated activity reacted with cDTPA in normal saline to yield [²⁰¹Tl](III)DTPA at room temperature after 0.5 hour, followed by solid phase extraction purification using C₁₈ Sep-Pak column (radiochemical yield >95%). Radiochemical purity of more than 99% was obtained using RTLC with specific activity of about 260 GBq/mmol. The stability of the tracer was checked in the final product in the presence of human serum at 37 °C up to 3 days. The partition coefficient was also measured. The labeled compound was used in red blood cell (RBC) labeling. The cell uptake ratio was determined at 4, 25 and 37 °C up to 3 hours.     

Development of [<Superscript>64</Superscript>Cu]-DOTA-anti-CD20 for targeted therapy

Copper-64 was produced as a by-product of ⁵⁵Co via ⁶⁴Ni(p,n)⁶⁴Cu by 15 MeV proton bombardment of ^natNi resulting in a thick target yield of 5.31 MBq/μAh (143.5 μCi/μAh) and a radiochemical separation yield of 95% (radionuclide purity >97% after 25 hours of bombardment). Rituximab was successively labeled with [⁶⁴Cu]-CuCl₂. N-succinimidyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA-NHS) was prepared at 25 °C using DOTA and N-hydroxy succinimide (NHS) in CH₂Cl₂ followed by the addition of 1 ml of a Rituximab pharmaceutical solution. Radiolabeling was performed at 37 °C in 3 hours. Radio thin-layer chromatography showed an overall radiochemical purity of 90–95% at optimized conditions (specific activity=30 GBq/mg, labeling efficacy; 82%) using various chromatography systems. The final isotonic ⁶⁴Cu-DOTA-Rituximab complex was passed through a 0.22 μm filter and checked by gel electrophoresis for radiolysis control. Stability of the final product was checked in the formulation and in presence of human serum at 37 °C.     

Preparation and preliminary evaluation of [<Superscript>67</Superscript>Ga]-tetra phenyl porphyrin complexes as possible imaging agents

[⁶⁷Ga]labeled tetraphenyl porphyrin ([⁶⁷Ga]-TPP) was prepared using freshly prepared [⁶⁷Ga]GaCl₃ and tetraphenyl porphyrin (TPPH₂) for 30–60 min at 25 °C (radiochemical purity: >97 ± 1% ITLC, >98 ± 0.5% HPLC, specific activity: 13–14 GBq/mmol). Stability of the complex was checked in final formulation and human serum for 24 h. The partition coefficient was calculated for the compound (log P 1.89). The biodistribution of the labeled compound in vital organs of wild-type rats was studied using scarification studies and SPECT imaging up to 24 h. A detailed comparative pharmacokinetic study performed for ⁶⁷Ga cation and [⁶⁷Ga]-TPP. The complex is mostly washed out from the circulation through kidneys and can be an interesting tumor imaging/targeting agent due to low liver uptake and rapid excretion through the urinary tract.     

Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent

Porphyrins are interesting derivatives with low toxicity, tumor avidity and rapid wash-out suggested as potential radiopharmaceuticals in radiolabeled form. In this work, [¹⁶⁶Ho] labeled 5,10,15,20-tetrakis(phenyl) porphyrin ([¹⁶⁶Ho]-TPP) was prepared using [¹⁶⁶Ho]HoCl₃ and 5,10,15,20-tetrakis(phenyl)porphyrin (H₂TPP) for 12 h at 50 °C (radiochemical purity: >95 ± 2 % ITLC, >99 ± 0.5 % HPLC, specific activity: 0.9–1.1 GBq/mmol). Stability of the complex was checked in final formulation and human serum for 48 h. The partition coefficient was calculated for the compound (log P = 2.01). The biodistribution of the labeled compound in vital organs of wild-type rats was studied using scarification studies and SPECT. A detailed comparative pharmacokinetic study performed for ¹⁶⁶Ho cation and [¹⁶⁶Ho]-TPP performed up to 24 h. The complex is mostly washed out from the circulation through kidneys and in less extends from the liver. The kidney:blood, kidney:liver and kidney:muscle ratios 4 h post injection were 14, 3.6 and 7.38 respectively.     

(η3-allyl)palladium(II) catalysts for the addition polymerization of norbornene derivatives with functional groups

Cycloaliphatic polyolefins with functional groups were prepared by the Pd(II)-catalyzed addition polymerization of norbornene derivatives. Homo- and copolymers containing repeating units based on bicyclo[2.2.1] hept-5-en-2-ylmethyl decanoate (endo/exo-ratio = 80/20), bicyclo[2.2.1]hept-5-ene-2-carboxylic acid methyl ester (exo/endo = 80/20), bicyclo[2.2.1]hept-5-ene-2-methanol (endo/exo = 80/20), and bicyclo[2.2.1]hept-5-ene-2-carboxylic acid (100% endo) were prepared in 49–99% yields with {(η³-allyl)Pd(BF₄)} and {(η³-allyl)Pd(SbF₆)} as catalysts. The catalyst containing the hexafluoroantimonate ion was slightly more active than the tetrafluoroborate based Pd-complex.     

Kinetics and mechanism of the substitution reactions of some monofunctional Pd(II) complexes with different nitrogen-donor heterocycles

Substitution reactions of five monofunctional Pd(II) complexes, [Pd(terpy)Cl]⁺ (terpy = 2,2′;6′,2″-terpyridine), [Pd(bpma)Cl]⁺ (bpma = bis(2-pyridylmethyl)amine), [Pd(dien)Cl]⁺ (dien = diethylenetriamine or 1,5-diamino-3-azapentane), [Pd(Me₄dien)Cl]⁺ (Me₄dien = 1,1,7,7-tetramethyldiethylenetriamine), and [Pd(Et₄dien)Cl]⁺ (Et₄dien = 1,1,7,7-tetraethyldiethylenetriamine), with unsaturated N-heterocycles such as 3-amino-4-iodo-pyrazole (pzI), 5-amino-4-bromo-3-methyl-pyrazole (pzBr), 1,2,4-triazole, pyrazole, pyrazine, and imidazole were investigated in aqueous 0.10 M NaClO₄ in the presence of 10 mM NaCl using variable-temperature stopped-flow spectrophotometry. The second-order rate constants k₂ indicate that the reactivity of the Pd(II) complexes decrease in the order [Pd(terpy)Cl]⁺ > [Pd(bpma)Cl]⁺ > [Pd(dien)Cl]⁺ > [Pd(Me₄dien)Cl]⁺ > [Pd(Et₄dien)Cl]⁺. The most reactive nucleophile of the heterocycles is pyrazine, while the slowest reactivity is with pyrazole. Activation parameters were determined for all reactions and negative entropies of activation, ΔS^≠, supporting an associative mode of substitution. The reactions between [Pd(bpma)Cl]⁺ and 1,2,4-triazole, pzI, and pzBr were also investigated by ¹H NMR to define the manner of coordination. These results could be useful for better explanation of structure-reactivity relationships of Pd(II) complexes as well as for the prediction of potential targets of Pd(II) complexes toward common N-heterocycles, constituents of biomolecules and different N-bonding pharmaceutical agents.     

Thermal and Spectroscopy Investigation of Cyclopalladated Compounds of the Type [Pd(C13H10N)(μ-X)]2, (X=H3CCOO,NCO, SCN,CN)

The dimeric compound [Pd(bzan)(μ-OOCCH₃)]₂ (1) (bzan=N-benzylideneaniline) reacts with KX, in methanol/acetone (2:1), affording the analogous dimeric pseudohalogen-bridged species [Pd(bzan)(μ-X)]₂ [X=NCO(2),SCN(3), CN(4)]. The compounds were characterized by elemental analysis, infrared spectroscopy, NMR and thermogravimetric analysis. IR data for 2–4 showed bands typical of coordinated pseudohalogen ligands clearly indicating the occurrence of the exchange reaction. Their thermal behaviour was investigated and suggested that their stability is influenced by the bridging ligand. The thermal stability decreased in the order[Pd(bzan)(μ-CN)]₂>[Pd(bzan)(μ-SCN)]₂>[Pd(bzan)(μ-OOCCH₃)]₂>[Pd(bzan)(μ-NCO)]₂. X-ray results showed the formation of Pd° as final decomposition product. This revised version was published online in July 2006 with corrections to the Cover Date.     

Preparation, nano purification, quality control and labeling optimization of [64Cu]-5,10,15,20-tetrakis (penta fluoro phenyl) porphyrin complex as a possible imaging agent

Cu-64 was produced via the ⁶⁸Zn (p,αn)⁶⁴Cu nuclear reaction (≈200 mCi, >95 % chemical yield at 180 μA for 1.1 h irradiation, (radionuclidic purity >96 %, copper-67 as impurity) followed by purification with amino functionalized nano magnetic oxide, Fe₃O₄ aiming to remove trace amount of heavy metal ions from aqueous media due to achieve ultra pure [⁶⁴Cu] CuCl₂ for labeling step. [⁶⁴Cu] labeled 5,10,15,20-tetrakis(penta fluoro phenyl) porphyrin ([⁶⁴Cu]-TFPP) was prepared using freshly prepared [⁶⁴Cu] CuCl₂ (Cu-64; T _1/2 = 12.7 h) and 5,10,15,20-tetrakis(penta fluoro phenyl)porphyrin (H₂TFPP) for 60 min at 100 °C under reflux condition (radiochemical purity: >97 % ITLC, >98 % HPLC, specific activity: 14–16 GBq/mmol). Stability of the complex was checked in final formulation and human serum for 24 h. The partition coefficient was calculated for the compound (log P = 0.73). The biodistribution of the labeled compound in vital organs of wild-type rats was studied using scarification studies and PET imaging up in 2 and 4 h after injection. A detailed comparative pharmacokinetic study performed for ⁶⁴Cu cation and [⁶⁴Cu]-TFPP. The complex is mostly washed out from the circulation through kidneys and liver and can be an interesting tumor imaging/targeting agent due to high specific uptake and rapid excretion through the urinary tract.     

Radiosynthesis and biodistribution studies of [62Zn/62Cu]–plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging

In order to develop a possible C-X-C chemokine receptor type 4 (CXCR4) imaging agent for oncological scintigraphy, [⁶²Zn]labeled 1,1′-[1,4-phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane ([⁶²Zn]-AMD3100) was prepared using in-house made [⁶²Zn]ZnCl₂ and AMD-3100 for 1 h at 50 °C (radiochemical purity: >97 % ITLC, >96 % HPLC, specific activity: 20–22 GBq/mmol) in acetate buffer. The complex showed highly hydrophilic properties (log P = ?1.114). Stability of the complex was checked in presence of human serum (37 °C) and in final formulation for 1 day. The biodistribution of the labeled compound in vital organs of wild-type Sprague–Dawdley rats were determined and compared with that of free Zn²⁺ cation up to 6 h. Co-incidence imaging of the complex was consistent with the distribution data up to 3 h. The complex can be a possible in vivo generator compound for PET imaging in CXCR4 positive tumors.     

Solvent extraction of no-carrier-added 103Pd from irradiated rhodium target with a-furyldioxime

Summary Solvent extraction of no-carrier-added ¹⁰³Pd was investigated from irradiated rhodium target with a-furyldioxime in chloroform from diluted hydrochloric acid. Extraction yield was 85.3% for a single extraction from 0.37M HCl and ¹⁰³Pd purity was better than 99%.     

THE STEREOCHEMISTRY OF DEALKYLATION STEP IN THE ARBUZOV REACTION INVOLVING FIVE-COORDINATE INTERMEDIATE. EVIDENCE FOR EQUILIBRIUM BETWEEN PHOSPHORANE AND PHOSPHONIUM SPECIES

Abstract

The oxidative addition of molecules X–Y to three-coordinated phosphorus compounds is of considerable general interest. If one of the groups attached to the phosphorus atom is an alkoxy, OR, the final product is almost always > P(O)Y with the formation of an alkyl halide RX. The above process is known as Arbuzov reaction, the mechanism of which can be represented, in the light of our present knowledge, as follows: mental mechanistic problem for the Arbuzov reaction.

The R(?)phosphite (4) was prepared from R(+)2-octanol of 95% opt. purity, [α]²⁰ _D + 9.4° (neat) and the chlorophosphite (3) by standard condensation in the presence of tertiary amine and purified by distilla tion in vacuo, δ³¹P ?127.5 ppm, [α]^D ₂₀ ?25.6° (neat). Equimolar amounts of the phosphite (4) and the corresponding halogen in CH2 C12 solution were allowed     

L-Carnitine. Novel Synthesis and Determination of the Optical Purity

A new route to L-carnitine ( 1 ) based on the resolution of th trimethylammonium derivative 5 is described. The enantiomeric purity of 1 is determined by ¹H-NMR of its O-acetyl hydrochloride 11 using [Eu(hfc)₃] as chiral shift reagent. The optical rotation of 1 with an enantiomeric purity ≥99% is [α] =?31.3° (c = 10, H₂O).     

Sulfur‐assisted Chloride and Triphenylphosphine Dissociation of Palladium(II) Complex with Phenyloxythiocarbonyl,PhOC(S), Containing Ligand: X‐Ray Structure of [Pd(PPh3)2{η1‐C(S)OPh}(Cl)]

Treatment of Pd(PPh₃)₄ with phenylchlorothionoformate, PhOC(S)Cl, in dichloromethane at ?20 °C produces the phenyloxythiocarbonyl complex [Pd(PPh₃)₂{η¹‐C(S)OPh}(Cl)], 1 . The ³¹P{¹H} NMR spectrum of 1 shows the dissociation of either the chloride or the triphenylphosphine ligand to form complex [Pd(PPh₃)₂(η²‐SCOPh)][Cl], 2 or the dipalladium complex [Pd(PPh₃)Cl]₂(μ,η²‐SCOPh)₂, 3 . Continuous stirring of the dichloromethane solution of 1 at room temperature for 4 h forms the dipalladinum complex [Pd(PPh₃)Cl]₂(μ,η²‐SCOPh)₂, 3 as the final product. Respective reactions of 1 and Et₂NCS₂Na or dppa {bis(diphenylphosphino)amine} gives complex [Pd(PPh₃){η¹‐C(S)OPh}(η²‐S₂CNEt₂)], 4 or [Pd(PPh₃){η¹‐C(S)OPh}(η²‐dppa)][Cl], 5 . Complex 1 is determined by single‐crystal X‐ray diffraction and crystallized in the monoclinic space group P2₁ with Z = 4. The cell dimensions of 1 are as follows: a = 9.5613(1) Å, b = 33.6732(3) Å, c = 12.2979(1) Å.     

Synthesis of a palladium complex bearing 2‐phenylbenzothiazole and its application to Suzuki–Miyaura coupling reaction

The palladacycle complex [L^sPdOAc]₂ bearing 2‐phenyl benzothiazole was synthesized and characterized by NMR and X‐ray crystallography. [L^sPdOAc]₂ was used as a catalyst in the Suzuki–Miyaura cross coupling reaction of 4‐bromotoluene with phenylboronic acid, which resulted in a conversion of >90% with 5 mol% of the Pd complex within 10 min at 60°C.     

Influence of the reaction parameters on the Pd—HCl catalysed synthesis of phenylacetic acid derivatives via reduction of mandelic acid derivatives with carbon monoxide

The catalytic system Pd/C—HCl is highly active in the reduction of mandelic acid derivatives to phenylacetic acid derivatives with carbon monoxide when the aromatic ring is para-substituted with a hydroxy group. Typical reaction conditions are: 70–110 °C, 20–100 atm of carbon monoxide, benzene—ethanol as reaction medium, substrate/Pd=10²–10⁴/1, HCl/substrate=0.3–0.8/1. [Pd] = 10⁻² −10⁻⁴ M. When the catalytic system is used in combination with PPh₃ a slightly higher activity is observed. Comparable results are observed when using a Pd(II) catalyst precursor such as PdX₂, in combination with PPh₃, or PdX₂(PPh₃)₂ (XCl, AcO). When operating at 110 °C, decomposition to metallic palladium occurs. Pd(II) complexes with diphosphine ligands, such as diphenylphosphinemethane, -ethane, -propane or -butane, do not show any catalytic activity and are recovered unchanged. These observations suggest that Pd(0) complexes play a key role in the catalytic cycle. The proposed catalytic cycle proceeds as follows: the chloride ArCHClCOOR, formed in situ upon reaction of ArCHOHCOOR with hydrochloric acid, oxidatively adds to a Pd(0) species with formation of a catalytic intermediate having a Pd—[CH(Ar)COOR] moiety, which inserts a CO molecule, yielding an acyl intermediate of the type Pd—[COCH(Ar)COOR]. The nucleophilic attack of H₂O on the carbon atom of the carbonyl ligand gives back the Pd(0) complex to the catalytic cycle and yields a phenylmalonic acid derivative, which produces the final product, ArCH₂COOR, upon CO₂ evolution. Alternatively, protonolysis of the intermediate having a Pd—[CH(Ar)COOR] moiety yields directly the final product and a Pd(II) species, which is then reduced by CO to Pd(0). Moreover, no catalytic activity is observed when the Pd/C—HCl system is used in combination with any one of the above diphosphine ligands, probably because these ligands block the sites on the catalyst able to promote the catalytic cycle or because they prevent the reduction of Pd(II) to Pd(0). The influence of the following reaction parameters has been studied: concentration of HCl, PPh₃, palladium and substrate, pressure of carbon monoxide, the temperature, reaction time and solvent. The results are compared with those obtained in the carbonylation of aromatic aldehydes to phenylacetic acid derivatives catalyzed by the same system, for which it has been proposed that the catalysis occurs via carbonylation of the aldehyde to a mandelic acid derivative as an intermediate, which is further reduced with CO to yield the final product.     

Synthesis and Complexation of 1,2-Bis[(monoaza[15]crown-5)-N-yl]glyoxime. Crystal Structure of (1,2-Bis[(monoaza[15]crown-5)-N-yl]glyoximato)palladium(II)

A new vicinal dioxime ligand with two crown-ether groups, 1,2-bis[(monoaza[15]crown-5)-N-Yl]-glyoxime(LH₂), has been prepared from cyanogen di-N-oxide and monoaza[15]crown-5. Ni(II), Pd(II), and Pt(IV) complexes of LH₂ with or without alkali-metal ions bound to macrocyclic groups have been isolated. The high affinity of [Pd(LH)₂] and [Ni(LH)₂] for the K⁺ ion is observed in solvent extraction experiments. A single-crystal X-ray structure confirms the postulated geometry of [Pd(LH)₂]- The Pd-atom of the centro-symmetric molecule has square-planar PdN₄ coordination where Pd–N distances range from 1.978(3) to 1.970(3) Å. The N–Pd–N intraligand angle is 79.9(1)^°.     

Development of radiogallium–ethylenecysteamine cysteine complex as a possible renal imaging agent

[⁶⁷Ga]-ethylenecysteamine cysteine ([⁶⁷Ga]ECC) was prepared using freshly prepared [⁶⁷Ga]GaCl₃ and ethylenecysteamine cysteine (ECC) for 30 min at 90 °C (radiochemical purity ≈97 ± 0.88% ITLC, specific activity: 210 ± 5 GBq/mM). Stability of the complex was checked in human serum for 24 h at 37 °C. Partition co-efficient of the tracer in octanol:saline mixture was determined (log P; 0.8). The biodistribution of the radiolabeled compound in vital organs of wild-type rats were compared with that of free Ga³⁺ cation up to 48 h. Initial biodistribution results showed significant kidney excretion of the tracer comparable to that of homologous ^99mTc compound.     

Zur oxidativen Addition von 1-Halogenalk-1-inen – Synthese und Struktur von Phenylalkinylpalladium-Komplexen

On the Oxidative Addition of 1-Halogenalk-1-ynes – Synthesis and Structure of Phenylalkynylpalladium Complexes [Pd(PPh₃)₄] ( 2 ) reacts with IC≡CPh and ClC≡CPh in the sense of an oxidative addition to give trans-[Pd(C≡CPh)X(PPh₃)₂] (X = I: 3 a , X = Cl: 3 b ). As side products trans-[PdX₂(PPh₃)₂] (X = I: 4 a , X = Cl: 4 b ; < 10%) and PhC≡C–C≡CPh ( 5 ; X = I: ca 30%, X = Cl: < 4%) are formed. 3 a and 3 b were characterized by NMR (¹H, ¹³C, ³¹P) and IR spectroscopies as well as by X-ray single-crystal structure analyses. In the crystals of 3 a and 3 b isolated molecules were found. The Pd–C≡C–Ph unit is linear in 3 a and approximately linear in 3 b [Pd–C≡C 174.2(6)°, C≡C–C 179,0(7)°].     

A novel palladium catalyst for the polymerization of propargyl alcohol

Homogeneous polymerization of propargyl alcohol (OHP) with Pd (C?CCH₂OH)₂(PPh₃)₂ [Pd?C] catalyst in CHCl₃-CH₃OH mixed solvent system has been investigated. [Pd?C] was found to be a novel effective catalyst for the OHP polymerization. Some features, kinetic behavior, and effect of solvent for the OHP polymerization are described and discussed. The overall polymerization activation energy was found to be 75.6kJ/mol and the rate equation can be expressed as R_p = k_p[OHP] [Pd?C]^0.7, where k_p = 3.14 × 10^-4 L^0.7/ mol^0.7 S (60°C). Polypropargyl alcohol (POHP) obtained is a brown powder with a number-average molecular weight (M?_n) of 10³-2 × 10³, and soluble in MeOH, DMF, and DMSO. Conducting properties of the resulting POHP were investigated. © 1994 John Wiley & Sons, Inc.